Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Lips in health and in systemic sclerosis: relevant physiology, pathogenesis, existing therapeutic approaches and unmet needs

Mahmood M., Hughes M., McMahan Z., Shapiro L.

Laboratory Study on Autoimmune Research, published in J Scleroderma Relat Disord (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Scleroderma Relat Disord (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42233092
PMCID
PMC13224322
DOI
10.1136/jsrd-2026-000004

Abstract (original English)

Introduction Systemic sclerosis (SSc), or scleroderma, is a chronic autoimmune disease marked by excessive collagen deposition and vasculopathy. Oro-facial manifestations of SSc, particularly involving the lips, are common including microcheilia, microstomia, and the classic "mask-like" face, all of which greatly affect patient quality of life. This review explores the lips in both health and SSc. We examine factors affecting lip health, methods of assessment, SSc-specific impacts, and discuss available therapeutic approaches. Methods A comprehensive literature search was conducted via PubMed and Embase. All article types were considered from inception of the databases, and the search was last run on April 20, 2025. Results The lips play a critical role in facial expression, communication, and appearance. Anatomy is complex and relevant to SSc pathogenesis. Relevant factors include gender differences, aging patterns, ethnicity, and lifestyle. The pathogenesis of lip involvement in SSc is multifactorial. In SSc, dermal fillers, autologous fat transfer, and platelet-rich plasma therapy have been shown to at least transiently volumize the lips and alleviate tightness. There is a lack of data on long-term benefits as well as standardized assessment tools for lip involvement in SSc. Conclusion The impact of lip involvement in SSc presents significant unmet clinical needs. There is a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research